Table 6.
Changes in lipid profile after one year of intervention.
| Lipids | Group | Base line Mean (SD) |
95% CI | 1 Year Mean (SD) |
95% CI | p – value (within group) | % Change | p – value (between the groups) | |
|---|---|---|---|---|---|---|---|---|---|
| Total Chol. | >200 | Y | 221.33 (23.86) | 162.06–280.61 | 183.33 (65.73) | 20.03–346.63 | 0.19 | 17.16 | 0.22 |
| C | 219.33 (12.20) | 206.52–232.15 | 217.67 (29.31) | 186.90–248.43 | 0.76 | 14.78 | |||
| <200 | Y | 146.09 (25.13) | 140.05–152.13 | 159.59 (36.53) | 150.82–168.37 | 0.002* | 8.45 | 0.95 | |
| C | 146.12 (21.73) | 140.35–151.89 | 160.51 (33.97) | 151.49–169.52 | 0.001** | 9.85 | |||
| Total | Y | 151.24 (30.35) | 91.75–210.72 | 163.04 (38.01) | 88.54–237.53 | 0.007* | 7.80 | 0.61 | |
| C | 154.21 (29.92) | 95.56–212.85 | 167.43 (38.90) | 91.18–243.67 | 0.003* | 8.57 | |||
| TGLYD | ≥150 | Y | 228.00 (80.99) | 202.10–253.90 | 158.45 (60.17) | 139.20–177.70 | 0.001** | 30.50 | 0.37 |
| C | 237.46 (70.17) | 214.06–260.86 | 175.30 (60.00) | 155.29–195.30 | 0.001** | 26.30 | |||
| <150 | Y | 115.03 (20.73) | 107.56–122.51 | 114.88 (47.15) | 97.88–131.87 | 0.99 | 0.13 | 0.41 | |
| C | 116.93 (20.31) | 108.89–124.96 | 125.48 (45.85) | 107.34–143.62 | 0.23 | 8.20 | |||
| Total | Y | 180.19 (83.54) | 16.45–343.92 | 142.57 (62.9) | 19.28–265.85 | 0.001** | 20.87 | 0.03* | |
| C | 187.13 (78.74) | 32.79–341.46 | 155.28 (57.98) | 41.63–268.92 | 0.001** | 17.02 | |||
| HDL | <35 | Y | 30.17 (3.15) | 28.16–32.17 | 37.92 (6.99) | 33.47–42.36 | 0.001** | 25.68 | 0.57 |
| C | 29.75 (3.91) | 27.92–31.58 | 36.20 (11.80) | 30.68–41.72 | 0.03* | 21.68 | |||
| ≥35 | Y | 40.45 (4.81) | 39.33–41.58 | 40.21 (9.55) | 37.98–42.43 | 0.82 | 0.59 | 0.19 | |
| C | 40.77 (5.85) | 39.05–42.49 | 37.98 (8.66) | 35.43–40.52 | 0.01* | 6.84 | |||
| Total | Y | 38.67 (6.29) | 26.34–50.99 | 40.23 (9.30) | 22.00–58.45 | 0.19 | 4.034 | 0.003* | |
| C | 37.23 (7.39) | 22.74–51.71 | 37.17 (9.68) | 18.19–56.14 | 0.34 | 6.0 | |||
| LDL | ≥100 | Y | 122.52 (22.60) | 112.23–132.81 | 91.38 (43.04) | 71.79–110.98 | 0.01* | 25.41 | 0.01* |
| C | 114.67 (13.76) | 107.05–122.29 | 125.20 (33.87) | 106.44–143.96 | 0.27 | 9.18 | |||
| <100 | Y | 66.54 (19.75) | 61.72–71.36 | 92.19 (28.58) | 85.22–99.17 | 0.001** | 27.82 | 0.84 | |
| C | 69.27 (17.21) | 64.62–73.93 | 91.15 (29.57) | 83.15–99.14 | 0.001** | 31.58 | |||
| Total | Y | 75.97 (27.65) | 21.77–130.16 | 96.61 (29.51) | 38.77–154.44 | 0.001** | 27.16 | 0.75 | |
| C | 78.17 (24.15) | 30.83–125.50 | 98.77 (33.53) | 33.05–164.48 | 0.001** | 26.35 | |||
| VLDL | ≥40 | 55.42 (15.81) | 49.62–61.22 | 55.16 (36.89) | 41.63–68.70 | 0.91 | 0.46 | 0.37 | |
| 55.75 (13.67) | 51.12–60.38 | 48.50 (24.04) | 40.37–56.63 | 0.065 | 13.00 | ||||
| <40 | 26.52 (6.49) | 24.94–28.11 | 27.52 (14.27) | 24.04–31.00 | 0.57 | 3.77 | 0.70 | ||
| 26.99 (7.72) | 24.64–29.33 | 28.55 (12.60) | 24.71–32.38 | 0.46 | 5.46 | ||||
| Total | Y | 34.92 (16.28) | 3.01–66.82 | 28.51 (12.59) | 3.83–53.18 | 0.001** | 18.35 | 0.03* | |
| C | 36.21 (15.28) | 6.26–66.15 | 31.58 (13.22) | 5.66–57.49 | 0.03* | 11.95 |
*p < 0.05, **p < 0.001.
Legend: Table 6 shows significant differences between the groups where yoga-based lifestyle modification (Y) group showed better improvement in total triglycerides, total HDL, LDL in those with baseline more than or equal to 100 mg% and total VLDL as compared to physiotherapy-based lifestyle modification (C).
Abbreviations: Chol: Cholesterol; TLGYD: Triglycerides; LDL: Low Density Lipoproteins; HDL: High Density Lipoproteins; VLDL: Very Low Density Lipoproteins; Y: yoga group (yoga life style program); C: control (physiotherapy life style program); SD: standard deviation.